CC
DVAX

Centiva Capital’s Dynavax Technologies DVAX Stock Holding History

Centiva Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,724
Closed -$119K – 1854
2024
Q3 		$119K Buy
+10,724
New +$118K ﹤0.01% 1937
2023
Q3 		– Sell
-10,057
Closed -$130K – 1790
2023
Q2 		$130K Sell
10,057
-4,465
-31% -$50.9K ﹤0.01% 1417
2023
Q1 		$142K Buy
+14,522
New +$155K ﹤0.01% 1292
2021
Q3 		– Sell
-29,601
Closed -$292K – 1358
2021
Q2 		$292K Buy
+29,601
New +$269K 0.01% 1057

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Centiva Capital's DVAX Position: Q4 2024 in Review

Centiva Capital sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 10,724 shares — an estimated $119K sold.

Centiva Capital first reported a position in DVAX in Q2 2021 and held it in 4 quarters. The position peaked at $292K in Q2 2021. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

  • Centiva Capital reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 10,724 Dynavax Technologies shares in Q4 2024, an estimated $119K.
  • Centiva Capital first reported a position in Dynavax Technologies in Q2 2021 and held it in 4 quarters.
  • Centiva Capital's Dynavax Technologies position peaked at $292K in Q2 2021.
  • 256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.